NCT06372561

Brief Summary

The process of dental caries is dynamic and can be either reversible or irreversible depending on the balance between protective and pathologic factors in the oral cavity. Untreated dental caries causes pulpal injury, inflammation, and necrosis. Melatonin plays an essential role in the regulation of bone growth. The actions that melatonin exerts on odontoblasts may be similar to its action on osteoblasts.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 31, 2023

Completed
6 months until next milestone

First Posted

Study publicly available on registry

April 18, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2024

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2024

Completed
Last Updated

August 2, 2024

Status Verified

August 1, 2024

Enrollment Period

1.3 years

First QC Date

October 31, 2023

Last Update Submit

August 1, 2024

Conditions

Outcome Measures

Primary Outcomes (8)

  • Clinically assessment (Modified visual analogue scale)

    Pain, sensitivity to percussion (scale values from 0 to 10) 0 means no pain and 10 means the worst pain with failure of the treatment.

    Immediately after apexogenesis procedure, after 1 month, 3 months, 6 months, 9 months and 12 months

  • Clinically assessment (Millar's index)

    tooth mobility (classes I,II,III) from less mobility to higher mobility.

    Immediately after apexogenesis procedure, after 1 month, 3 months, 6 months, 9 months and 12 months

  • Clinically assessment (presence or abscence)

    changes in mucobuccal folds (swelling, redness, abscess,fistula)

    Immediately after apexogenesis procedure, after 1 month, 3 months, 6 months, 9 months and 12 months

  • Radiographic assessment (using Image J software program)

    Density of calcific tissue (dentinal bridge) underneath MTA, Melatonin and their mixture (the 3 groups) (Densitometric analysis)

    Immediately after apexogenesis procedure, after 1 month, 3 months, 6 months, 9 months and 12 months

  • Radiographic assessment (using Image J software program)

    Thickness of calcific tissue (dentinal bridge) underneath MTA, Melatonin and their mixture (the 3 groups)

    Immediately after apexogenesis procedure, after 1 month, 3 months, 6 months, 9 months and 12 months

  • Radiographic assessment (using Image J software program)

    Width of apical foramina for the 3 groups.

    Immediately after apexogenesis procedure, after 1 month, 3 months, 6 months, 9 months and 12 months

  • Radiographic assessment (using Image J software program)

    Linear radiographic measurement of root development.

    Immediately after apexogenesis procedure, after 1 month, 3 months, 6 months, 9 months and 12 months

  • Radiographic assessment (using Image J software program)

    Assessment of changes in bone density surrounding the treated teeth (Densiometric analysis)

    Immediately after apexogenesis procedure, after 1 month, 3 months, 6 months, 9 months and 12 months

Study Arms (3)

Mineral Trioxide Aggregate

ACTIVE COMPARATOR

is a powder that consist of Calcium oxide, silicone dioxide, aluminum oxide, bismuth oxide, purified water. It is a bactericidal dressing material, promotes pulp healing, and does so without producing inflammation and promotes dentin bridge formation.

Drug: Mineral trioxide aggregate (dressing material)

Melatonin

EXPERIMENTAL

(N-acetyl-5-methoxy-tryptamine) is a pleiotropic hormone synthesized in the pineal gland that has important chronobiotic properties. there is a Melatonin drug (powder) that proved to play an essential role in the regulation of bone growth (bone regeneration) and it may promote osteoblast differentiation, and stimulates mineralized matrix formation

Drug: Melatonin (dressing material)

Mineral Trioxide and Melatonin

EXPERIMENTAL

Mixture of the two materials' powders.

Drug: Mineral trioxide aggregate (dressing material)Drug: Melatonin (dressing material)

Interventions

MTA (Angulus Industrial de productus Odontologists S/a, Brazil) that applied on dental pulp for tissue regeneration

Also known as: MTA
Mineral Trioxide AggregateMineral Trioxide and Melatonin

melatonin powder 250mg (sigma, Aldrich)- white powder mixing with saline and applied on dental pulp

Also known as: N-acetyl-5-methoxy-tryptamine
MelatoninMineral Trioxide and Melatonin

Eligibility Criteria

Age6 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Apparently healthy and medically free children. 2- Their age ranges from 6-8 years. 3- Both boys and girls will be included. 4- Children should have mandibular permanent first molars with the following clinical and radiographic criteria. 4.1Restorable young permanent first molars. 4.2Absence of clinical evidence of pulp degeneration:
  • No history of spontaneous pain, history of night pain or pain that not relieved by analgesics.
  • No pain on percussion.
  • No mobility.
  • Absence of abscess, purulent sinus or soft tissue edema.
  • Bleeding should stop within 5 minutes after the amputated pulp stumps.

You may not qualify if:

  • Internal root resorption.
  • External root resorption.
  • Inter radicular or periapical bone destruction (radiolucency)
  • A deep carious lesion radiologically that approaches the pulp

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine, Suez canal university

Ismailia, 41522, Egypt

RECRUITING

Related Publications (3)

  • Guerrero-Girones J, Alcaina-Lorente A, Ortiz-Ruiz C, Ortiz-Ruiz E, Pecci-Lloret MP, Rodriguez-Lozano FJ, Martinez CM, Ortiz-Ruiz AJ. Melatonin as an Agent for Direct Pulp-Capping Treatment. Int J Environ Res Public Health. 2020 Feb 6;17(3):1043. doi: 10.3390/ijerph17031043.

  • Liu Q, Fan W, He Y, Zhang F, Guan X, Deng Q, Lu X, He H, Huang F. Effects of melatonin on the proliferation and differentiation of human dental pulp cells. Arch Oral Biol. 2017 Nov;83:33-39. doi: 10.1016/j.archoralbio.2017.06.034. Epub 2017 Jun 30.

  • Vaseenon S, Chattipakorn N, Chattipakorn SC. Effects of melatonin in wound healing of dental pulp and periodontium: Evidence from in vitro, in vivo and clinical studies. Arch Oral Biol. 2021 Mar;123:105037. doi: 10.1016/j.archoralbio.2020.105037. Epub 2021 Jan 6.

MeSH Terms

Interventions

mineral trioxide aggregatePemetrexedMelatonin

Intervention Hierarchy (Ancestors)

GuanineHypoxanthinesPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsGlutamatesAmino Acids, AcidicAmino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, DicarboxylicTryptaminesIndolesHormonesHormones, Hormone Substitutes, and Hormone Antagonists

Study Officials

  • Gihan GED El-Desouky, Professor

    Professor

    PRINCIPAL INVESTIGATOR
  • Ghada AH Elbaz, Professor

    Professor

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mennatallah Hesham El shaabany, doctorate student

CONTACT

Asmaa Ali Abo El-Soud, Associate professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 31, 2023

First Posted

April 18, 2024

Study Start

May 20, 2023

Primary Completion

September 20, 2024

Study Completion

October 2, 2024

Last Updated

August 2, 2024

Record last verified: 2024-08

Locations